Tag: AVeNEW
Interventional News Issue 95—August 2024 US Edition
Interventional News 95 Highlights:
Findings from a post-hoc analysis of Lutonix arteriovenous (AV) global registry data
Interview with Philip Dombrowski (Cape Cod Hospital, Hyannis,...
Interventional News Issue 95—August 2024 Edition
Interventional News 95 Highlights:
Findings from a post-hoc analysis of Lutonix arteriovenous (AV) global registry data
Interview with Philip Dombrowski (Cape Cod Hospital, Hyannis,...
AVeNEW trial shows superior AVF target lesion patency with covered stent...
“Study design is critically important when interpreting outcomes,” said Bart Dolmatch (Mountain View Hospital, Mountain View, USA) in his evaluation of the “disconnect” between...
Early AVeNEW trial results were “quite compelling”
Throwback to the 2019 Society of Interventional Radiology annual scientific meeting when Interventional News interviewed Bart Dolmatch (Mountain View, USA) on the early results of the AVeNEW trial - the first Level One trial dedicated solely to assess the safety...
Covered stent provides greater patency than angioplasty alone in AV fistulae
The Covera vascular covered stent (BD) has a superior six-month primary patency rate than standard balloon angioplasty, with an equivalent safety at 30 days,...
